Multi-Omics Analysis of Ileal Mucosa and Mesentery Before and After Ileocecal Resection in Crohn’s Disease

The multi-omics analysis of ileal mucosa and mesentery before and after ileocecal resection in Crohn’s disease (CD) provides valuable insights into how surgical intervention influences the disease at both microbial and metabolic levels. This study employs an integrated approach to analyze paired samples from patients with active and remission-stage CD, focusing on the spatial changes in the microbiome and metabolome within the ileal mucosa and mesentery.

Key Findings:

1. Microbial Alterations:

• Improved Microbial Health: Ileocecal resection is associated with a significant improvement in microbial health in both the ileal mucosa and mesentery.
• Reduction in Dysbiosis: Post-surgery, there is a decrease in dysbiosis (microbial imbalance), with restoration of microbial diversity and balance.
• Decline in Proinflammatory Bacteria: Bacterial taxa previously linked to epithelial barrier disruption, immune activation, and inflammation are significantly reduced after surgery.
• Gut–Mesentery Axis: The study highlights that microbial changes are not limited to the intestinal lumen but extend into the mesenteric tissues, emphasizing the role of the gut–mesentery axis in CD pathogenesis.

2. Metabolic Alterations:

• Shifts in Metabolic Pathways: Postoperative changes in metabolic profiles are observed, particularly in pathways related to:
• Lipid metabolism
• Amino acid metabolism
• Immune signaling
• Gut barrier function
• Microbe–Metabolite Interactions: Specific altered metabolites correlate with microbial changes, suggesting an interplay between microbes and metabolites that contributes to mucosal healing and immune regulation.
• Key Pathways: Tryptophan metabolism and lipid signaling emerge as critical pathways potentially involved in promoting postoperative remission.

3. Spatial Analysis:

• The study provides a spatially resolved view of changes in both the ileal mucosa and mesentery. This dual analysis reveals that the mesentery, often overlooked in CD research, plays a significant role in the pathogenesis and remission of the disease.

4. Therapeutic Implications:

• Early Surgical Intervention: The findings support the therapeutic value of early ileocecal resection in selected CD patients, as it leads to microbial and metabolic improvements associated with disease remission.
• Microbiome-Based Strategies: Insights from this study may inform the development of microbiome-targeted therapies or precision treatments to manage CD more effectively.

Significance of the Study:

This is the first study to comprehensively map the microbiome and metabolome changes in both the ileal mucosa and mesentery before and after ileocecal resection. By integrating microbial and metabolic data, the research provides a deeper understanding of the biological mechanisms underlying postoperative remission in CD. It highlights the importance of considering the mesentery as an integral component of CD pathogenesis and remission, paving the way for novel therapeutic strategies aimed at restoring gut and mesenteric health.

In summary, the multi-omics analysis underscores the complex interplay between gut microbiota, host immunity, and metabolism in Crohn’s disease and demonstrates how surgical intervention can modulate these interactions to promote remission.